secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2026-09-14T21:22:12+00:00
Accession:  0001654954-26-008347
Event type: earnings
Sentiment:  positive
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q3 revenue up ~$0.4M YoY; net loss narrows to $14K
------------------------------------------------------------------

- Q3 (ended July 31, 2026) revenue ~$2.3M, up ~$0.4M YoY; nine-month revenue ~$7.3M, up ~$0.5M YoY.
- Q3 net loss of $14K, an ~$190K improvement YoY; nine-month net income ~$252K, up ~$352K YoY.
- CEO Victor Sanchez credits client relationships and specialized compliance capabilities for improved performance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495426008347/0001654954-26-008347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495426008347/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-26-008347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer